Gio’s Law

Summary

Creates a new federal effort around law enforcement use of epinephrine by (1) adding a statutory grant program for law enforcement access to emergency epinephrine (text provided is a placeholder and contains no implementation or funding details), (2) requiring the Attorney General, through the Bureau of Justice Statistics, to publish annual nationwide data on how often federal, state, local, and tribal officers administer epinephrine products, and (3) directing the Attorney General, with HHS, to run an interagency public awareness campaign about anaphylaxis symptoms and the role of officers and first responders in administering epinephrine, to begin within 180 days of enactment. The bill sets reporting and campaign duties but does not specify appropriations, operational rules for the grant program, start dates for reporting, or enforcement penalties.

• Adds a short title for the Act.
• Creates a new law enforcement emergency epinephrine grant program in statute, but the submitted text is only a placeholder without funding or implementation details.
• Requires the Attorney General (via BJS) to publish annual data on how often federal, state, local, and tribal officers administer epinephrine products.
• Directs the Attorney General and HHS to launch a public awareness campaign about anaphylaxis and responders' roles within 180 days of enactment.
• Does not specify appropriations, eligibility rules, definitions, data collection methods, or penalties for noncompliance.
• Imposes reporting and campaign duties on federal agencies but provides no explicit funding or start dates for reporting beyond 'annual.'
• Could increase public knowledge of anaphylaxis and encourage broader availability or use of epinephrine by first responders if implemented and funded.
• Implementation will likely require follow-up rules, budget action, or agency guidance because the grant program language is incomplete.